Feedback / Questions
envudeucitinib (ESK-001) - Alumis
A-005 - Alumis
https://www.globenewswire.com/news-release/2025/08/13/3132978/0/en/Alumis-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html
Aug 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next